Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives

US10577359B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10577359-B2
Application numberUS-201715425198-A
CountryUS
Kind codeB2
Filing dateFeb 6, 2017
Priority dateSep 14, 2004
Publication dateMar 3, 2020
Grant dateMar 3, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides (i) processes for preparing a 2′-deoxy-2′-fluoro-2′-methyl-D-ribonolactone derivatives, (ii) conversion of intermediate lactones to nucleosides with potent anti-HCV activity, and their analogues, and (iii) methods to prepare the anti-HCV nucleosides containing the 2′-deoxy-2′-fluoro-2′-C-methyl-ß-D-ribofuranosyl nucleosides from a preformed, preferably naturally-occurring, nucleoside.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula 51B: wherein: each R 1 is independently (C 1 -C 6 ) alkyl, phenyl or benzyl; or two R 1 with the carbon attached thereto form a cyclopentyl or cyclohexanyl group; R 2 is hydrogen, (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl; R 3 is (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl; R 4 is hydrogen, aryl, arylalkyl or (C 1 -C 6 ) alkyl; Nu is F, Cl, Br, N 3 , CN, NO 3 , CF 3 , SCN, OR or NR 2 where each R is independently arylalkyl or (C 1 -C 6 ) alkyl; and M + is tetrabutylammonium, tetraethylammonium, tetramethylammonium, sodium, potassium, cesium, rubidium or silver. 2. A compound of formula 52B: wherein: each R 1 is independently (C 1 -C 6 ) alkyl, phenyl or benzyl; or two R 1 with the carbon attached thereto form a cyclopentyl or cyclohexanyl group; R 2 is hydrogen, (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethnyl, allyl or haloallyl; R 3 is (C 1 -C 6 ) alkyl, hydroxymethyl, methoxymethyl, halomethyl, vinyl, halovinyl, ethynyl, haloethynyl, allyl or haloallyl; R 4 is hydrogen, aryl, arylalkyl or (C 1 -C 6 ) alkyl; and Nu is F, Cl, Br, N 3 , CN, NO 3 , CF 3 , SCN, OR or NR 2 where each R is independently arylalkyl or (C 1 -C 6 ) alkyl.

Assignees

Inventors

Classifications

  • for RNA viruses · CPC title

  • Oxygen atoms · CPC title

  • Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems · CPC title

  • Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • in position 2, the oxygen atom being in its keto or unsubstituted enol form · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10577359B2 cover?
The present invention provides (i) processes for preparing a 2′-deoxy-2′-fluoro-2′-methyl-D-ribonolactone derivatives, (ii) conversion of intermediate lactones to nucleosides with potent anti-HCV activity, and their analogues, and (iii) methods to prepare the anti-HCV nucleosides containing the 2′-deoxy-2′-fluoro-2′-C-methyl-ß-D-ribofuranosyl nucleosides from a preformed, preferably naturally-o…
Who is the assignee on this patent?
Gilead Pharmasset Llc
What technology area does this patent fall under?
Primary CPC classification C07D411/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).